(R)-N-[4,4-BIS(3-METHYL-2-THIENYL)BUT-3-EN-1-YL]NIPECOTIC ACID BINDS WITH HIGH-AFFINITY TO THE BRAIN GAMMA-AMINOBUTYRIC ACID UPTAKE CARRIER

被引:214
|
作者
BRAESTRUP, C
NIELSEN, EB
SONNEWALD, U
KNUTSEN, LJS
ANDERSEN, KE
JANSEN, JA
FREDERIKSEN, K
ANDERSEN, PH
MORTENSEN, A
SUZDAK, PD
机构
[1] Pharmaceuticals R&D, Novo Industri A/S, Bagsvaerd
关键词
(R)‐N‐[4,4‐Bis(3‐methyl‐2‐thienyl)but‐3‐en‐1 ‐yl]nipecotic acid hydrochloride; Astrocytes; Neurons; Rat brain; [!sup]3[!/sup]H]NO 328; γ‐Aminobutyric acid uptake;
D O I
10.1111/j.1471-4159.1990.tb01919.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(R)‐N‐[4,4‐Bis(3‐methyl‐2‐thienyl)but‐3‐en‐l‐yl]nipecotic acid (NO 328) has previously been shown to be a potent anticonvulsant in both mice and rats. Here, we report that NO 328 is a potent inhibitor of γ‐[3H]aminobutyric acid ([3H]GABA) uptake in a rat forebrain synaptosomal preparation (IC50= 67 nM) and in primary cultures of neurons and astrocytes. Inhibition of [3H]GABA uptake by NO 328 is apparently of a mixed type when NO 328 is preincubated before [3H]GABA uptake; the inhibition is apparently competitive without preincubation. NO 328 itself is not a substrate for the GABA uptake carrier, but NO 328 is a selective inhibitor of [3H]GABA uptake. Binding to benzodiazepine receptors, histamine H1 receptors, and 5‐hydroxytryptaminelA receptors was inhibited by NO 328 at 5—30 μM, whereas several other receptors and uptake sites were unaffected. [3H]NO 328 showed saturable and reversible binding to rat brain membranes in the presence of NaCI. The specific binding of [3H]NO 328 was inhibited by known inhibitors of [3H]GABA uptake; GABA and the cyclic amino acid GABA uptake inhibitors were, however, less potent than expected. This indicates that the binding site is not identical to, but rather overlapping with, the GABA recognition site of the uptake carrier. The affinity constant for binding of [3H]NO 328 is 18 nM, and the Bmax is 669 pmol/g of original rat forebrain tissue. The regional distribution of NaCl‐dependent [3H]NO 328 binding followed that of synaptosomal [3H]GABA uptake. It is concluded that NO 328 is a potent and selective inhibitor of neuronal and glial GABA uptake and that [3H]NO 328 is a useful radioligand for labeling the GABA uptake carrier in brain membranes. In the mouse brain in vivo, [3H]NO 328 likewise showed saturable and reversible binding that could be displaced by analogues of NO 328. Further studies are needed to demonstrate whether the uptake carrier is indeed labeled by [3H]NO 328 in vivo. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:639 / 647
页数:9
相关论文
共 15 条
  • [1] ASSOCIATION OF [H-3] NIPECOTIC ACID BINDING WITH THE HIGH-AFFINITY GAMMA-AMINOBUTYRIC-ACID UPTAKE SYSTEM IN HUMAN-BRAIN
    SIMPSON, MDC
    CROSS, AJ
    DEAKIN, JFW
    SLATER, P
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (06) : 1247 - 1248
  • [2] THE SYNTHESIS OF NOVEL GABA UPTAKE INHIBITORS .1. ELUCIDATION OF THE STRUCTURE-ACTIVITY STUDIES LEADING TO THE CHOICE OF (R)-1-[4,4-BIS(3-METHYL-2-THIENYL)-3-BUTENYL]-3-PIPERIDINECARBOXYLIC ACID (TIAGABINE) AS AN ANTICONVULSANT DRUG CANDIDATE
    ANDERSEN, KE
    BRAESTRUP, C
    GRONWALD, FC
    JORGENSEN, AS
    NIELSEN, EB
    SONNEWALD, U
    SORENSEN, PO
    SUZDAK, PD
    KNUTSEN, LJS
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (12) : 1716 - 1725
  • [3] Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4,4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat
    Cleton, A
    de Greef, HJMM
    Edelbroek, PM
    Voskuyl, RA
    Danhof, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (08) : 1651 - 1658
  • [4] BINDING OF [H-3] 3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID TO RAT-BRAIN MEMBRANES - A SELECTIVE, HIGH-AFFINITY LIGAND FOR N-METHYL-D-ASPARTATE RECEPTORS
    MURPHY, DE
    SCHNEIDER, J
    BOEHM, C
    LEHMANN, J
    WILLIAMS, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 240 (03): : 778 - 784
  • [5] Diastereoselective synthesis of (-)-1-methyl-(3S,4R)-3,4-bis((2S)-N-(tert-butyloxycarbonyl)pyrrolidin-2-yl)-2-pyrrolidinone by an asymmetric Michael reaction
    Mahboobi, S
    Popp, A
    Burgemeister, T
    Schollmeyer, D
    TETRAHEDRON-ASYMMETRY, 1998, 9 (13) : 2369 - 2376
  • [6] REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF THE ENANTIOMERS OF N-[4,4-DI(3-METHYLTHIEN-2-YL)-BUT-3-ENYL] NIPECOTIC ACID ON A PIRKLE-TYPE PHENYLGLYCINE STATIONARY PHASE
    RUSTUM, AM
    GUTIERREZ, L
    JOURNAL OF CHROMATOGRAPHY, 1990, 503 (01): : 115 - 125
  • [7] Crystal structure of 4,4′-bis(pyridin-1-ium-4-yl)biphenyl poly[bis(μ2-4,4′-bis(pyrid-4-yl)biphenyl-κ2N:N′)-tetrakis(μ4-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-κ4 O,O′:O":O"′)-bis[[μ2-1,′-biphenyl]-3-carboxyl-5-carboxylato-κ2O:O′]tetracobalt(II)]-[1,1′-biphenyl]-3,5-dicarboxylic acid (1/2), C93H68N3O16CO2
    Tang, Qian-Qian
    Li, Shi-Hui
    Cheng, Zhan-Quan
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1209 - 1212
  • [8] IDENTIFICATION OF A PYRIDINIUM METABOLITE IN HUMAN URINE FOLLOWING A SINGLE ORAL DOSE OF 1-[2-[BIS[4-(TRIFLUORO-METHYL)PHENYL]METHOXY]ETHYL]-1,2,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLIC ACID MONOHYDROCHLORIDE, A GAMMA-AMINOBUTYRIC-ACID UPTAKE INHIBITOR
    RADULOVIC, L
    WOOLF, T
    BJORGE, S
    TAYLOR, C
    REILY, M
    BOCKBRADER, H
    CHANG, T
    CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (03) : 341 - 344
  • [9] Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction
    Wang, Yuji
    Kang, Guifeng
    Liu, Jiawang
    Zhao, Ming
    Wu, Jianhui
    Zhang, Xiaoyi
    Li, Ye
    Zhong, Xiaobo
    Yang, Yifan
    Peng, Shiqi
    METALLOMICS, 2012, 4 (05) : 441 - 447
  • [10] The Discovery of N-((2H-Tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist
    DeMong, Duane
    Dai, Xing
    Hwa, Joyce
    Miller, Michael
    Lin, Sue-Ing
    Kang, Ling
    Stamford, Andrew
    Greenlee, William
    Yu, Wensheng
    Wong, Michael
    Lavey, Brian
    Kozlowski, Joseph
    Zhou, Guowei
    Yang, De-Yi
    Patel, Bhuneshwari
    Soriano, Aileen
    Zhai, Ying
    Sondey, Christopher
    Zhang, Hongtao
    Lachowicz, Jean
    Grotz, Diane
    Cox, Kathleen
    Morrison, Richard
    Andreani, Teresa
    Cao, Yang
    Liang, Mark
    Meng, Tao
    McNamara, Paul
    Wong, Jesse
    Bradley, Prudence
    Feng, Kung-I
    Belani, Jitendra
    Chen, Ping
    Dai, Peng
    Gauuan, Jolicia
    Lin, Peishan
    Zhao, He
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2601 - 2610